A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis
NCT02058264 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2022-12-16
Summary
The purpose of this study is to determine the safety, tolerability, pharmacokinetics and treatment effect of BBI-4000 when topically applied to subjects with axillary hyperhidrosis.
Conditions
- Hyperhidrosis
Interventions
- DRUG
-
BBI-4000
Sponsors & Collaborators
-
Botanix Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-02-28
- Primary Completion
- 2014-08-31
- Completion
- 2014-09-30
More Related Trials
-
The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia
NCT02300233 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease
NCT01609140 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina
NCT00185263 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
NCT02993406 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of SRSD216 in Patients With Elevated Lipoprotein (a)
NCT07172646 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
BGB-DXP604 Alone and in Combination With BGB-DXP593 in Healthy Participants
NCT04669262 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of IBI306 in Chinese Subjects With Non-familial Hypercholesterolemia
NCT04289285 ·Status: COMPLETED ·Phase: PHASE3
-
The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy
NCT02653833 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk
NCT02991118 ·Status: COMPLETED ·Phase: PHASE3
-
BIIB014 Effects on the Pharmacokinetics (PK) of Rosiglitazone, Warfarin, and Midazolam
NCT01017666 ·Status: COMPLETED ·Phase: PHASE1
-
Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction
NCT03041259 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermittent Claudication
NCT00725881 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease
NCT05762952 ·Status: RECRUITING ·Phase: PHASE1
-
Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia
NCT02215824 ·Status: TERMINATED ·Phase: PHASE1
-
Model System for Transient Forearm Blood Vessel Dysfunction
NCT00453531 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Trial for Dose Finding and Safety of RVX000222 in Subjects With Stable Coronary Artery Disease
NCT01058018 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
NCT03508609 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events
NCT01730534 ·Status: COMPLETED ·Phase: PHASE3
-
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
NCT01975389 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014)
NCT01294709 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study of BNS003 on Swelling in Legs Due to Venous Reflux
NCT02211898 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Patients With Mixed Dyslipidemia
NCT06497127 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
NCT00556439 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 Administered Alone or With Dabigatran Etexilate
NCT01688830 ·Status: COMPLETED ·Phase: PHASE1